Zaleplon

DRUG6 trials

Sponsors

Roxane Laboratories, St. Luke's Hospital, Chesterfield, Missouri, Hannover Medical School, University of California, San Diego, University of Pennsylvania

Conditions

Anxiety DisordersClinical DepressionDementiaDepressionHIV/AIDSMemoryPsychosomatic DisordersSchizophrenia

Phase 2

Zaleplon in HIV Patients With Depression

CompletedNCT03489304

University of PennsylvaniaClinical Depression, HIV/AIDS

Start: 2014-04-03End: 2015-02-04Updated: 2018-10-16

Phase 3

Pharmacovigilance in Gerontopsychiatric Patients

TerminatedNCT02374567

Hannover Medical SchoolAnxiety Disorders, Dementia, Depression +2

Start: 2015-01-31End: 2017-06-28Updated: 2018-02-28

Phase 4

Hypnotic Medications and Memory: Effect of Drug Exposure During the Night

CompletedNCT01159652

St. Luke's Hospital, Chesterfield, MissouriMemory, Sleep

Start: 2010-10-31End: 2011-05-31Updated: 2014-08-26

Unknown Phase

Bioequivalency Study of Zaleplon 10 mg Capsules Under Fed Conditions

CompletedNCT00694317

Roxane LaboratoriesShort Term Treatment of Insomnia

Start: 2004-02-29End: 2004-02-29Updated: 2018-01-23

Bioequivalency Study of Zaleplon 10 mg Capsules Under Fasting Conditions

CompletedNCT00694187

Roxane LaboratoriesShort Term Treatment of Insomnia

Start: 2004-01-31End: 2004-02-29Updated: 2018-01-23

Cerebral MRI During Sleep

CompletedNCT03304652

University of California, San DiegoSleep

Start: 2017-10-01End: 2018-10-31Updated: 2019-03-14